Health care industry
US Agriculture Secretary Ann M. Veneman announced additional measures to bolster the US protection systems against Bovine Spongiform Encephalopathy (BSE). These measures aim to further protect public health by strengthening protections against BSE, removing specified risk materials and tissues from the human food chain, and implementing a verifiable system of
Health care industry
As the markets begin a new year, EquityOutlook.Com provides a timely evaluation of top stocks to watch. Using their proprietary system of technical analysis, the company has identified several stocks that exhibit potential for short-term price movement relative to the S&P 500. Dell Computer, Cmgi Inc, and
Health care industry
StockPickReport.Com, a stock research firm, has made public its short-term stock evaluations for several prominent companies, including Dell Computer, Micron Technology Inc., Xilinx Inc., Tenet Healthcare Corp, and AT&T Corp. The firm's proprietary unbiased system of technical analysis assigns a rating of "Outperform"
Health care industry
Researchers at Yale University have developed an immunotherapy treatment for cancer that targets both the tumor vasculature and tumor cells, demonstrating promising results in treating human solid tumors. The treatment involves systemic delivery of an immunoconjugate molecule composed of a tumor-targeting domain conjugated to the Fc effector domain of human
Health care industry
A phase II trial involving a prostate cancer vaccine has demonstrated encouraging outcomes, with 58% of participants remaining responsive to treatment after an average follow-up period of 291 and 557 days. The study, published in Prostate, used an autologous dendritic cell vaccine in combination with two human histocompatibility antigen (HLA-A2)
Health care industry
CEL-SCI Corporation announced that the Czech Republic's State Institute for Drug Control has granted permission to start a Phase II clinical trial with CEL-SCI's immunotherapeutic drug, Multikine. This multicenter study, being conducted in Poland and the Czech Republic, aims to enroll 30 patients with squamous cell
Health care industry
Researchers at the University of Padua, Italy, have made a significant breakthrough in cancer therapy with the development of methoxymorpholinyl doxorubicin (MMDX) delivered by interleukin-2 (IL-2)-activated natural killer (NK) cells. In a study published in the British Journal of Cancer, L. Quintieri and colleagues demonstrated the efficacy of this
Health care industry
Recent findings suggest that vascular endothelial growth factor (VEGF) may play a significant role in tumor angiogenesis and metastatic potential. A study published in the International Journal of Cancer investigated the effects of VEGF on tumor growth and metastasis in a human fibrosarcoma cell model. The results indicate that VEGF
Health care industry
Recent research has shown that Kaposi's Sarcoma Associated Herpes Virus (KSHV) infection of primary endothelial cells results in long-term transformation and upregulation of vascular endothelial growth factor receptor-2 (KDR), leading to dysregulated endothelial cell proliferation. This study investigated the effect of neutralizing monoclonal antibodies to KDR on KSHV-induced
Health care industry
As the world grapples with the metabolic side effects of protease inhibitors, a new class of highly active antiretroviral therapy (HAART) regimens is gaining attention. Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is proving to be a potent member of its class, with promising results from ongoing clinical trials. In
Health care industry
University of Washington researchers have made significant progress in an AIDS immunotherapy study, expanding HIV-specific cytotoxic lymphocytes (CTLs) ex vivo and reinfusing them into patients. The study found that the CTLs made it to the lymph nodes, where HIV-infected cells congregate, and aggregated there. However, the cells were short-lived in
Health care industry
Texans living with HIV/AIDS have a vital resource to help them navigate the complex world of treatment options, thanks to the Texas AIDS Health Fraud Information Network (TAHFIN). This statewide task force, sponsored by the U.S. Food and Drug Administration (FDA), provides up-to-date information on treatment fraud issues
